Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
53 studies found for:    "Epidermolysis Bullosa" OR "junctional epidermolysis bullosa"
Show Display Options
Rank Status Study
1 Terminated
Has Results
Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)
Conditions: Epidermolysis Bullosa, Junctional;   Epidermolysis Bullosa Dystrophica
Interventions: Device: Apligraf;   Other: Standard dressing regimen
2 Completed
Has Results
Study of Alwextin® Cream in Treating Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: Alwextin cream
3 Terminated
Has Results
Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Procedure: hematopoietic bone marrow transplantation
4 Terminated A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing
Condition: Epidermolysis Bullosa
Interventions: Biological: ABH001;   Other: Control wound treatment
5 Active, not recruiting Open Label Extension Study to Evaluate the Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: SD-101 dermal cream (6%)
6 Completed Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: 3% SD-101 dermal cream;   Drug: 6% SD-101 dermal cream;   Drug: Vehicle (0% SD-101)
7 Completed The Efficacy of Trimethoprim in Wound Healing of Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: Trimethoprim
8 Recruiting ESSENCE Study: Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: SD-101-6.0 cream;   Drug: SD-101-0.0 cream
9 Active, not recruiting Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: Zorblisa (SD-101-6.0) cream
10 Recruiting Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention: Other: Allogeneic mesenchymal stem cells
11 Withdrawn A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Interventions: Biological: HP802-247;   Other: Placebo
12 Completed Case Series Documentation of Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa Hereditaria
Intervention: Drug: Sericare®
13 Terminated
Has Results
A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: Thymosin Beta 4;   Drug: Placebo
14 Unknown  Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Condition: Epidermolysis Bullosa
Intervention: Drug: Reduced Intensity Transplant conditioning
15 Recruiting Stem Cell Transplant for Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Anti-thymocyte globulin;   Drug: Cyclosporine A;   Drug: Mycophenolate mofetil;   Procedure: Mesenchymal stem cell transplantation;   Radiation: Total body irradiation;   Procedure: Bone marrow or umbilical cord blood (UCG) stem cell transplantation
16 Withdrawn Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous Keratinocytes
Condition: Epidermolysis Bullosa
Intervention: Procedure: Grafting of Autologous Cultured Revertant Keratinocytes
17 Withdrawn Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention:
18 Recruiting Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: topical BPM31510 3.0% Cream
19 Completed Study of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling Meara
Condition: Epidermolysis Bullosa Simplex Dowling Meara
Intervention: Procedure: Taking of liquid and top of blisters
20 Unknown  Randomised Double Blind Crossover Placebo Controlled Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: tetracyclin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.